{
  "meta": {
    "title": "Ini_Cet_May_2024",
    "url": "https://brainandscalpel.vercel.app/ini-cet-may-2024-1edba2b3.html",
    "scrapedAt": "2025-11-30T07:34:55.978Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Furosemide</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrochlorothiazide</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Empagliflozin </span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\"> A 60-year-old diabetic patient presents with symptoms of exertional dyspnea and pedal edema of one-year duration. Auscultation revealed bilateral crepitations. Echocardiography shows reduced ejection fraction. Which of the following reduces the progression of heart disease in this patient?</span></p>",
      "unique_key": "DT1324028",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324028,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Cardiovascular Benefits of Drugs</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250506c3c6413d-958a-4279-82a1-7f93c3c2819c.jpg\">\n<ol>\n<li><strong>SGLT-2 Inhibitors and HF: </strong>Sodium-glucose cotransporter-2 (SGLT-2) inhibitors have been shown to reduce the incidence of heart failure (HF) in diabetic patients, suggesting potential benefits for patients with established HF.</li>\n<li><strong>Dapagliflozin in HFrEF: </strong>The addition of dapagliflozin, an SGLT-2 inhibitor, to guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF) has led to reductions in cardiovascular mortality and heart failure hospitalizations. This was observed in the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure (DAPA-HF) study, which included patients both with and without diabetes.</li>\n<li><strong>Ongoing Clinical Trials: </strong>Current trials like the Dapagliflozin Evaluation to Improve the Lives of Patients with Preserved Ejection Fraction Heart Failure (DELIVER; NCT03619213) and the Empagliflozin Outcome Trial in Patients with Chronic Heart Failure with Preserved Ejection Fraction (EMPEROR-PRESERVED; NCT03057951) are exploring the effectiveness of these drugs in patients with heart failure with preserved ejection fraction (HFpEF). These trials aim to determine if the benefits seen in HFrEF can be extended to this group, regardless of their diabetes status.<strong> </strong></li>\n</ol>\n<p><strong>Incorrect Choices Explanation:</strong></p>\n<ul>\n<li><strong>Choice A: Furosemide (Loop Diuretic)</strong>\n<ul>\n<li><strong>Provides symptomatic relief </strong>by reducing congestion (pulmonary edema, pedal edema) but <strong>does not improve survival or slow disease progression</strong>.</li>\n<li><strong>No impact on long-term cardiovascular mortality</strong>.</li>\n</ul>\n</li>\n<li><strong>Choice B: Hydrochlorothiazide (Thiazide Diuretic)</strong>\n<ul>\n<li><strong>Primarily used for hypertension </strong>and mild fluid overload.</li>\n<li>Less effective than loop diuretics in <strong>managing HF-related volume overload</strong>.</li>\n<li><strong>No proven mortality benefit</strong>in HFrEF.</li>\n</ul>\n</li>\n<li><strong>Choice D: Digoxin</strong>\n<ul>\n<li><strong>Used for symptomatic relief in HF and atrial fibrillation</strong>, but <strong>does not reduce mortality</strong>.</li>\n<li><strong>Increased mortality risk in women</strong>(as observed in studies).</li>\n<li>Primarily <strong>improves cardiac contractility and reduces hospitalizations</strong>, but has <strong>narrow therapeutic index and risk of toxicity</strong>.</li>\n</ul>\n</li>\n</ul>\n<h3><strong>Key Takeaway:</strong></h3>\n<ul>\n<li>SGLT2 inhibitors (e.g., Empagliflozin, Dapagliflozin) are now a first-line therapy for heart failure with reduced ejection fraction (HFrEF) in diabetic and non-diabetic patients, reducing cardiovascular mortality and hospitalization rates.</li>\n<li>Loop diuretics (e.g., Furosemide) and Digoxin improve symptoms but do not slow disease progression.</li>\n</ul>",
      "correct_choice_id": 3,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Metformin </span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Glimepiride</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Sitagliptin</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Dapagliflozin </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old patient with chronic heart failure presented with worsening dyspnea and uncontrolled diabetes mellitus with HBA1c of 7.8%. Which is the preferred antidiabetic drug? \r\n</span></p>",
      "unique_key": "DT1324029",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324029,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>SGLT-2 inhibitors in diabetes with heart failure:</strong></p>\r\n<ol>\r\n<li><strong>Cardiovascular Risk Reduction:</strong>\r\n<ul>\r\n<li>SGLT-2 inhibitors have demonstrated effectiveness in reducing cardiovascular events and mortality among patients with type 2 diabetes who are at high cardiovascular risk or have established atherosclerotic cardiovascular disease.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Empagliflozin Cardiovascular Outcome Event Trial (EMPA-REG OUTCOMES):</strong>\r\n<ul>\r\n<li>The EMPA-REG OUTCOMES study specifically noted a 35% reduction in the incidence of heart failure (HF) hospitalizations compared to placebo.</li>\r\n<li>This benefit was notable as it suggests the potential for broad cardiovascular protective effects of SGLT-2 inhibitors.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Independence from Glycaemic Control:</strong>\r\n<ul>\r\n<li>The cardiovascular advantages of using SGLT-2 inhibitors appear to be independent of changes in hemoglobin A1c levels, indicating a direct cardiovascular protective effect rather than one mediated solely through improved blood sugar control.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Consensus on SGLT-2 Inhibitors:</strong>\r\n<ul>\r\n<li>The findings from these studies have influenced consensus guidelines to recommend SGLT-2 inhibitors as foundational therapy for heart failure.</li>\r\n<li>These guidelines suggest pairing SGLT-2 inhibitors with ARNI, beta-blockers, and mineralocorticoid receptor antagonists for comprehensive management of heart failure.</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<h4><strong>Incorrect Choices Explanation:</strong></h4>\r\n<ul>\r\n<li><strong>Choice A: Metformin</strong>\r\n<ul>\r\n<li>First-line drug in T2DM, but its use in heart failure is controversial, particularly in advanced stages due to the risk of lactic acidosis.</li>\r\n<li>Not the best option when a better cardioprotective drug (SGLT2 inhibitor) is available.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Choice B: Glimepiride (Sulfonylurea)</strong>\r\n<ul>\r\n<li>Associated with an increased risk of hypoglycemia.</li>\r\n<li>No proven cardiovascular benefit.</li>\r\n<li>May cause weight gain, which worsens heart failure.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Choice C: Sitagliptin (DPP-4 Inhibitor)</strong>\r\n<ul>\r\n<li>Neutral effect on heart failure outcomes (TECOS trial).</li>\r\n<li>Does not reduce heart failure hospitalizations or cardiovascular mortality.</li>\r\n<li>Less effective than SGLT2 inhibitors in cardiovascular risk reduction.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<h3><strong>Key Takeaway:</strong></h3>\r\n<ul>\r\n<li>Dapagliflozin (SGLT2 inhibitor) is the preferred antidiabetic drug for patients with both heart failure and diabetes, as it significantly reduces cardiovascular mortality and heart failure hospitalizations.</li>\r\n<li>Metformin is cautiously used, while sulfonylureas and DPP-4 inhibitors do not provide additional cardiovascular benefits.</li>\r\n</ul>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Metformin</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Sitagliptin </span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Glimepiride</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Pioglitazone\r\n</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\"> In a diabetic patient with unexplained diarrhea, which drug is most likely to be implicated? \r\n\r\n</span></p>",
      "unique_key": "DT1324030",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324030,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202505068042ce89-0710-4075-974f-c0e98c85b449.jpg\">\n<p>Diarrhea is a common side effect associated with metformin, one of the most widely prescribed medications for the treatment of type 2 diabetes mellitus. Here's a detailed explanation of why it occurs, its prevalence, and how it can be managed:</p>\n<p><strong>Mechanism</strong></p>\n<ul>\n<li><strong>Intestinal Absorption:</strong>Metformin primarily affects the gastrointestinal tract where it is mostly absorbed. It increases intestinal glucose utilization, which can alter bowel motility.</li>\n<li><strong>Altered Microbiota:</strong>Metformin has been shown to change the composition of the gut microbiota, which may contribute to gastrointestinal side effects including diarrhea.</li>\n<li><strong>Lactic Acidosis:</strong>Although rare, metformin can cause lactic acidosis, a condition that increases lactate production in the gut and can lead to diarrhea.</li>\n<li><strong>Commonality:</strong>Diarrhea is one of the most common side effects of metformin, affecting about 10% to 30% of those who take it.</li>\n<li><strong>Early Use:</strong>Diarrhea is more likely to occur during the initial stages of treatment as the body adjusts to the medication.</li>\n</ul>\n<h4><strong>Incorrect Choices Explanation:</strong></h4>\n<ul>\n<li><strong>Choice B: Sitagliptin (DPP-4 Inhibitor)</strong>\n<ul>\n<li><strong>Generally well-tolerated</strong>, but can cause mild GI discomfort.</li>\n<li><strong>Diarrhea is uncommon </strong>with sitagliptin.</li>\n</ul>\n</li>\n<li><strong>Choice C: Glimepiride (Sulfonylurea)</strong>\n<ul>\n<li><strong>Does not commonly cause diarrhea</strong>.</li>\n<li>More associated with <strong>hypoglycemia and weight gain</strong>.</li>\n</ul>\n</li>\n<li><strong>Choice D: Pioglitazone (Thiazolidinedione, TZD)</strong>\n<ul>\n<li><strong>Does not cause diarrhea</strong>, but is linked to <strong>fluid retention, weight gain, and heart failure exacerbation</strong>.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<ul>\n<li>Metformin is the most likely cause of unexplained diarrhea in diabetic patients.</li>\n<li>Switching to an extended-release formulation or reducing the dose can help manage symptoms.</li>\n</ul>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum glucose more than 250 mg/dL</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Ph < 7.3</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum bicarbonate < 15 mEq/L </span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum potassium < 3.5 mEq/L\r\n</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are criteria for diagnosis of diabetic ketoacidosis, except? \r\n</span></p>",
      "unique_key": "DT1324031",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324031,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Laboratory Abnormalities in DKA</strong></p>\r\n<ol>\r\n<li><strong>Hyperglycemia:</strong>Serum glucose levels are typically 13.9 mmol/L (250 mg/dL), although in cases of euglycemic DKA, often associated with SGLT2 inhibitor use, glucose levels may be lower or even normal.</li>\r\n<li><strong>Ketosis:</strong>Presence of ketone bodies in the blood, with -hydroxybutyrate being synthesized at a rate three times greater than acetoacetate. However, acetoacetate is more commonly detected in routine tests.</li>\r\n<li><strong>Metabolic Acidosis:</strong>Characterized by a serum bicarbonate 15 18 mmol/L and an increased anion gap. Arterial pH typically ranges between 6.8 and 7.3.</li>\r\n<li><strong>Altered Electrolytes:</strong>\r\n<ul>\r\n<li><strong>Potassium:</strong>Despite total-body potassium deficiency, serum potassium may appear normal or elevated due to acidosis and volume depletion.</li>\r\n<li><strong>Sodium:</strong>Hyponatremia is common due to the osmotic shift of water from intracellular to extracellular compartments in response to hyperglycemia. Corrected sodium levels should be considered.</li>\r\n<li><strong>Phosphorus and Magnesium:</strong>Total body stores are depleted, though serum levels may not accurately reflect this due to compensatory mechanisms.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Renal Function Markers:</strong>Elevated blood urea nitrogen (BUN) and creatinine levels indicative of intravascular volume depletion.</li>\r\n<li><strong>Other Findings:</strong>\r\n<ul>\r\n<li><strong>Leukocytosis:</strong>Often present even without infection.</li>\r\n<li><strong>Hypertriglyceridemia and Hyperlipoproteinemia:</strong>Frequently observed.</li>\r\n<li><strong>Hyperamylasemia:</strong>Can occur, but is typically of salivary origin and not indicative of pancreatitis.</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<p><strong>Diagnosis of DKA</strong></p>\r\n<ol>\r\n<li><strong>Clinical Presentation:</strong>Symptoms may include nausea, vomiting, polyuria, abdominal pain, and altered mental status ranging from lethargy to coma.</li>\r\n<li><strong>Ketone Detection:</strong>\r\n<ul>\r\n<li><strong>Urine Ketones:</strong>Commonly detected using nitroprusside tablets or sticks, which may give false positives with certain medications.</li>\r\n<li><strong>Serum/Plasma -Hydroxybutyrate:</strong>Preferred for more accurate quantification of ketosis.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Differential Diagnosis:</strong>Must differentiate DKA from other causes of high anion-gap metabolic acidosis such as starvation ketosis, alcoholic ketoacidosis, lactic acidosis, and Uremia.</li>\r\n</ol>\r\n<p><strong>Special Considerations</strong></p>\r\n<ul>\r\n<li><strong>False Positives in Testing:</strong>Certain medications like captopril and penicillamine may cause false-positive reactions in urine ketone tests.</li>\r\n<li><strong>Severity Assessment:</strong>The degree of acidosis and hyperglycemia may not directly correlate, as these depend on various factors including oral intake and urinary glucose loss.</li>\r\n</ul>\r\n<h3><strong>Incorrect Choices Explanation:</strong></h3>\r\n<ul>\r\n<li><strong>Choice A: Serum glucose 250 mg/dL</strong>\r\n<ul>\r\n<li>Hyperglycemia is a key diagnostic criterion for DKA.</li>\r\n<li>Exception: <strong>Euglycemic DKA</strong>(seen with SGLT2 inhibitors) where glucose levels may be lower.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Choice B: pH 7.3</strong>\r\n<ul>\r\n<li>Acidosis is a hallmark of DKA.</li>\r\n<li>Severity classification:\r\n<ul>\r\n<li>Mild DKA: pH <strong>25-7.30</strong></li>\r\n<li>Moderate DKA: pH <strong>00-7.24</strong></li>\r\n<li>Severe DKA: pH <strong>&lt;7.00</strong></li>\r\n</ul>\r\n</li>\r\n<li><strong>Choice C: Serum bicarbonate &lt;15 mEq/L</strong>\r\n<ul>\r\n<li>Reflects metabolic acidosis.</li>\r\n<li>Severe DKA: <strong>Serum bicarbonate &lt;10 mEq/L</strong></li>\r\n</ul>\r\n</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<h3><strong>Key Takeaway:</strong></h3>\r\n<ul>\r\n<li>DKA diagnostic criteria include hyperglycemia, metabolic acidosis, and ketosis.</li>\r\n<li>Serum potassium &lt;3.5 mEq/L is NOT a diagnostic criterion but indicates severe depletion requiring correction.</li>\r\n</ul>",
      "correct_choice_id": 34,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperthyroidism </span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperparathyroidism </span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypercortisolism </span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperaldosteronism\r\n</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\"> A 45-year-old man presents to the outpatient department with proximal muscle weakness, purple stretch marks, obesity, easy bruising. What is the underlying condition? \r\n</span></p>",
      "unique_key": "DT1324032",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324032,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Clinical Manifestations of Cushing's Syndrome:</strong></p>\r\n<ol>\r\n<li><strong>General Features</strong>: Obesity, diabetes, diastolic hypertension, hirsutism, and depression are common but nonspecific symptoms of Cushing's syndrome.</li>\r\n<li><strong>Dermatological Signs</strong>: Notable for fragile skin with easy bruising and broad, purplish striae wider than 1 cm.</li>\r\n<li><strong>Muscle Weakness</strong>: Proximal myopathy is evident, especially when performing actions like standing up from a chair without using hands or climbing stairs.</li>\r\n<li><strong>Mineralocorticoid Effects</strong>: Manifest as diastolic hypertension, hypokalemia, and edema due to cortisol's mineralocorticoid activity.</li>\r\n<li><strong>Reproductive and Thyroid Function</strong>: Suppression of gonadotropins leading to hypogonadism and amenorrhea; decreased thyroid-stimulating hormone (TSH) secretion.</li>\r\n<li><strong>Hyperpigmentation</strong>: Seen in ectopic ACTH syndrome, affecting knuckles, scars, or areas exposed to increased friction.</li>\r\n<li><strong>Psychiatric Symptoms</strong>: Include anxiety, depression, and in severe cases, paranoid or depressive psychosis.</li>\r\n<li><strong>Long-Term Health Risks</strong>: Increased risk of cardiovascular disease, osteoporosis, and vertebral fractures.</li>\r\n</ol>\r\n<p><strong>Option:</strong></p>\r\n<ul>\r\n<li><strong>A) Hyperthyroidism</strong>: Incorrect because hyperthyroidism typically presents with symptoms like weight loss, increased appetite, nervousness, and heat intolerance, not the specific signs of Cushing's syndrome such as proximal muscle weakness and purplish striae.</li>\r\n<li><strong>B) Hyperparathyroidism</strong>: Incorrect as primary symptoms include hypercalcemia, kidney stones, bone pain, and abdominal discomfort. It doesn't typically cause obesity, muscle weakness, or skin changes as described.</li>\r\n<li><strong>C) Hypercortisolism</strong>: Correct because it directly aligns with all symptoms presented by the patient: obesity, muscle weakness, purple stretch marks, and easy bruising are hallmark signs of cortisol excess or Cushing's syndrome.</li>\r\n<li><strong>D) Hyperaldosteronism</strong>: Incorrect as it primarily causes hypertension and hypokalemia. While some overlap in symptoms exists (e.g., hypertension), hyperaldosteronism does not typically present with muscle weakness, purple stretch marks, or significant changes in skin appearance.</li>\r\n</ul>\r\n<h3><strong>Incorrect Choices Explanation:</strong></h3>\r\n<ul>\r\n<li><strong>Choice A: Hyperthyroidism </strong>\r\n<ul>\r\n<li>Presents with <strong>weight loss</strong>, heat intolerance, tremors, and tachycardia-not central obesity, purple striae, or proximal myopathy.</li>\r\n<li>No significant skin changes like easy bruising.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Choice B: Hyperparathyroidism </strong>\r\n<ul>\r\n<li>Presents with <strong>hypercalcemia-related symptoms</strong>(bones, stones, abdominal groans, psychic moans).</li>\r\n<li>No characteristic skin findings or central obesity.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Choice D: Hyperaldosteronism </strong>\r\n<ul>\r\n<li>Features <strong>hypertension, hypokalemia, metabolic alkalosis</strong>.</li>\r\n<li>No striae, easy bruising, or central obesity.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<h3><strong>Key Takeaway:</strong></h3>\r\n<p>Hypercortisolism (Cushings Syndrome) presents with central obesity, proximal muscle weakness, purple striae, and easy bruising-hallmark features that distinguish it from other endocrine disorders.</p>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperthyroidism </span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Pioglitazone </span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Dapagliflozin </span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Metformin </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following anti-diabetic agents is associated with increased risk of urinary tract infection? </span></p>",
      "unique_key": "DT1324033",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324033,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<h1>Side Effects of Anti-Diabetic Agents</h1>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250509aa4a4030-6d1a-47a3-89f4-c6cdb6c02f54.JPG\">\n<p>Risk of UTI in SGLT-2 Inhibitor Therapy</p>\n<p>SGLT-2 inhibitors like dapagliflozin function by preventing the reabsorption of glucose in the kidneys, leading to its excretion through urine. This mechanism increases glucose concentration in the urinary tract, which can promote the growth of bacteria and yeast, thereby raising the risk of developing urinary tract and genital infections. Symptoms may include a burning sensation during urination, increased frequency of urination, urgency, and pelvic pain. It is important for patients on SGLT-2 inhibitors to maintain good personal hygiene and report any symptoms of urinary tract infections to their healthcare provider promptly. Treatment typically involves the use of antibiotics or antifungals depending on the pathogen involved. Monitoring for signs of UTI and educating patients about the symptoms are critical aspects of care.</p>\n<h3><strong>Incorrect Choices Explanation:</strong></h3>\n<ul>\n<li><strong>Choice A: Sitagliptin </strong>\n<ul>\n<li>A DPP-4 inhibitor, generally <strong>well tolerated</strong>.</li>\n<li>Rarely causes infections, with a low risk of UTI.</li>\n</ul>\n</li>\n<li><strong>Choice B: Pioglitazone </strong>\n<ul>\n<li>A thiazolidinedione (TZD), primarily associated with <strong>fluid retention, weight gain, and heart failure exacerbation</strong>.</li>\n<li>No direct link to increased UTI risk.</li>\n</ul>\n</li>\n<li><strong>Choice D: Metformin </strong>\n<ul>\n<li><strong>Most common side effects:</strong>GI upset (diarrhea, nausea), lactic acidosis (in renal impairment), vitamin B12 deficiency.</li>\n<li><strong>No increased risk of UTI.</strong></li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>SGLT-2 inhibitors (e.g., dapagliflozin) increase UTI risk due to glucosuria. Patients should be advised on hygiene and to report symptoms early.</p>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Subtrochanteric fracture </span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Loss of bone mass  </span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteosarcoma  </span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteonecrosis of jaw\r\n</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an adverse effect of long-term intermittent Teriparatide treatment for osteoporosis?</span></p>",
      "unique_key": "DT1324034",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324034,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<h1>Summary of Teriparatide Therapy</h1>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202505065700484a-adb0-401e-a003-5fc2599a50e0.jpg\">\r\n<p><strong>Incorrect Choices Explanation:</strong></p>\r\n<ul>\r\n<li><strong>Choice A: Subtrochanteric Fracture </strong>\r\n<ul>\r\n<li><strong>Not a known side effect of teriparatide.</strong></li>\r\n<li><strong>Atypical femoral fractures</strong>are associated with <strong>long-term bisphosphonate use</strong> due to suppressed bone turnover.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Choice B: Loss of Bone Mass </strong>\r\n<ul>\r\n<li>Teriparatide <strong>increases</strong>bone mass and <strong>improves bone microarchitecture</strong>.</li>\r\n<li>However, discontinuation without follow-up antiresorptive therapy (e.g., bisphosphonates) can lead to <strong>bone loss over time</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Choice D: Osteonecrosis of the Jaw (ONJ) </strong>\r\n<ul>\r\n<li>ONJ is primarily associated with <strong>bisphosphonates</strong>and <strong>denosumab</strong>, particularly in <strong>cancer patients receiving high doses</strong>.</li>\r\n<li>Teriparatide is <strong>not a known cause of ONJ</strong>; in fact, it may <strong>aid bone healing</strong>in some cases.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<h3><strong>Key Takeaway:</strong></h3>\r\n<p>Teriparatide is linked to osteosarcoma risk in animal studies, leading to a 2-year treatment limit, but human data do not show a significant risk.</p>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcitriol </span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Furosemide </span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Lithium</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Risedronate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following causes a decrease in serum parathyroid hormone? </span></p>",
      "unique_key": "DT1324035",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324035,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<h1>Parathyroid Hormone Physiology and Regulation</h1>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250509b072375d-5e0c-4a6e-8445-6b6c33a5b5fe.jpg\">\n<p><strong>Choice </strong><strong>A) Calcitriol (Correct Answer)</strong></p>\n<ul>\n<li><strong>Effect on PTH:</strong>Calcitriol, the active form of Vitamin D, directly suppresses the secretion of parathyroid hormone. It does this by enhancing the absorption of calcium from the gut, which increases serum calcium levels and subsequently inhibits PTH secretion through negative feedback.</li>\n<li><strong>Mechanism:</strong>Calcitriol binds to Vitamin D receptors in the parathyroid gland, decreasing PTH gene expression.<strong> </strong></li>\n</ul>\n<p><strong>Incorrect choices explanation :</strong><strong> </strong></p>\n<p><strong>Choice </strong><strong>B) Furosemide</strong></p>\n<ul>\n<li><strong>Effect on PTH:</strong>Furosemide, a loop diuretic, can actually lead to an increase in serum PTH. It causes increased calcium excretion in the urine, which can lead to hypocalcemia and subsequently stimulate PTH secretion.</li>\n<li><strong>Mechanism:</strong>By increasing renal calcium excretion, it lowers serum calcium levels, which in turn stimulates the parathyroid glands to produce more PTH to compensate.</li>\n</ul>\n<p><strong>Choice </strong><strong>C) Lithium</strong></p>\n<ul>\n<li><strong>Effect on PTH:</strong>Lithium use can lead to increased levels of PTH. Lithium has been associated with altering calcium homeostasis by increasing the set point at which calcium suppresses PTH secretion.</li>\n<li><strong>Mechanism:</strong>Lithium interferes with the calcium-sensing receptor (CaSR) in the parathyroid gland, making it less sensitive to calcium, which may lead to hyperparathyroidism.</li>\n</ul>\n<p><strong>Choice </strong><strong>D) Risedronate</strong></p>\n<ul>\n<li><strong>Effect on PTH:</strong>Risedronate, a bisphosphonate used to treat osteoporosis, does not directly lower PTH levels; however, it can indirectly affect them. By inhibiting bone resorption and increasing bone mineral density, it can lead to a transient increase in serum calcium, which might temporarily suppress PTH secretion.</li>\n<li><strong>Mechanism:</strong>Its primary action is to inhibit osteoclast-mediated bone resorption, potentially leading to increased serum calcium levels that could temporarily inhibit PTH secretion.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Calcitriol decreases PTH by increasing calcium absorption and directly inhibiting PTH gene expression.</p>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyelonephritis </span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Allergic interstitial nephritis</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">UTI</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Berger disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old boy presented with follicular tonsillitis. He was prescribed antibiotics. After a few days, the patient develops decreased urine output, rash and periorbital edema. What is the likely diagnosis? \r\n</span></p>",
      "unique_key": "DT1324036",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324036,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Choice B) Allergic Interstitial Nephritis (Correct Answer)</strong></p>\r\n<ul>\r\n<li><strong>Explanation</strong>: This condition is an immune reaction often triggered by medications, leading to kidney inflammation (interstitial nephritis). The symptoms described, including decreased urine output, rash, and periorbital edema, align well with allergic interstitial nephritis, particularly following the use of certain antibiotics.<strong>  </strong></li>\r\n</ul>\r\n<p><strong>Incorrect choices explanation : </strong></p>\r\n<p><strong>Choice </strong><strong>A) Pyelonephritis</strong></p>\r\n<ul>\r\n<li><strong>Explanation</strong>: Pyelonephritis is a kidney infection typically resulting from a bacterial UTI that spreads from the bladder to the kidneys. While it can present with decreased urine output and systemic symptoms, the specific combination of rash and periorbital edema is not characteristic of pyelonephritis.</li>\r\n</ul>\r\n<p><strong>Choice </strong><strong>C) UTI (Urinary Tract Infection)</strong></p>\r\n<ul>\r\n<li><strong>Explanation</strong>: While a UTI can involve decreased urine output if it progresses, the symptoms of rash and periorbital edema are not typically associated with a straightforward urinary tract infection.</li>\r\n</ul>\r\n<p><strong>Choice </strong><strong>D) Berger Disease (IgA Nephropathy)</strong></p>\r\n<ul>\r\n<li><strong>Explanation</strong>: Berger disease often presents with hematuria (blood in the urine) and may involve proteinuria, but it does not typically cause rash and periorbital edema in the context described without other systemic symptoms or signs of chronic kidney disease.<strong> </strong></li>\r\n</ul>\r\n<p><strong>Key Takeaway : </strong></p>\r\n<p><strong>Allergic Interstitial Nephritis:</strong></p>\r\n<ol>\r\n<li><strong>Incidence</strong>: Biopsy-proven AIN is an underestimated cause of acute kidney injury, accounting for about 15% of cases.</li>\r\n<li><strong>Clinical Presentation</strong>: Often does not include the classical trio of fever, rash, and eosinophilia. It's more common to find rising serum creatinine levels or symptoms of acute kidney injury incidentally.</li>\r\n<li><strong>Atypical Reactions</strong>: NSAIDs can cause AIN without the typical symptoms but with significant proteinuria.</li>\r\n<li><strong>Severe Reactions</strong>: Rapid onset of AIN can occur with reintroduction of certain drugs like rifampin.</li>\r\n<li><strong>Progressive Damage</strong>: Prolonged use of some medications like proton pump inhibitors might lead to chronic interstitial nephritis and eventually chronic kidney disease.</li>\r\n<li><strong>Diagnosis</strong>: Typically indicated by unexplained kidney injury and recent exposure to potential nephrotoxic agents. Peripheral eosinophilia and urinalysis showing pyuria and hematuria support the diagnosis.</li>\r\n<li><strong>Biopsy Findings</strong>: Not always required but shows infiltration by leukocytes, including eosinophils, in kidney interstitial and tubular areas.</li>\r\n</ol>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">RTA type 2 may be associated with bicarbonate </span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">RTA 4 is associated with hypokalemia</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">RTA 2 May present with Fanconi syndrome</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">RTA 4 is due to aldosterone resistance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Choose an incorrect statement about RTA? </span></p>",
      "unique_key": "DT1324037",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324037,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<h1>Renal Tubular Acidosis Types</h1>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250506214cf5a3-978e-42ba-9150-d0eb5ca9a7d0.jpg\">\r\n<h3><strong>Incorrect Choices Explanation:</strong></h3>\r\n<ul>\r\n<li><strong>Choice A: RTA Type 2 may be associated with bicarbonate loss (Correct Statement)</strong>\r\n<ul>\r\n<li><strong>Proximal tubule defect</strong>leads to <strong>impaired bicarbonate reabsorption</strong>, resulting in <strong>bicarbonaturia and metabolic acidosis</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Choice C: RTA Type 2 may present with Fanconi syndrome (Correct Statement)</strong>\r\n<ul>\r\n<li>Fanconi syndrome is characterized by <strong>proximal tubule dysfunction</strong>, causing loss of <strong>glucose, phosphate, amino acids, and bicarbonate</strong>.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Choice D: RTA Type 4 is due to aldosterone resistance (Correct Statement)</strong>\r\n<ul>\r\n<li><strong>Aldosterone deficiency or resistance</strong>leads to <strong>hyperkalemia</strong>, impaired ammonium excretion, and mild metabolic acidosis.</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<h3><strong>Key Takeaway:</strong></h3>\r\n<p>RTA Type 4 is associated with hyperkalemia, not hypokalemia.</p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis </span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis </span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old patient presented with nausea, vomiting and diarrhea. ABG results indicate pH of 7.55, paco2 of 50 mm, hco3 of 44 meq/l. What is the acid base disturbance? </span></p>",
      "unique_key": "DT1324038",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324038,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The given arterial blood gas (ABG) results for the 35-year-old patient show:</p>\n<ul>\n<li><strong>pH</strong>: 7.55</li>\n<li><strong>PaCO2</strong>: 50 mmHg</li>\n<li><strong>HCO3-</strong>: 44 mEq/L</li>\n</ul>\n<h3>Stepwise Explanation:</h3>\n<ol>\n<li><strong>Identify the pH</strong>: The normal range for arterial pH is 7.35 to 7.45. A pH of 7.55 indicates <strong>alkalosis</strong>.</li>\n<li><strong>Determine if it is Metabolic or Respiratory</strong>:\n<ul>\n<li><strong>PaCO2</strong>is 50 mmHg (normal range: 35-45 mmHg). This value is elevated, which normally would suggest respiratory acidosis if it were the primary disorder. However, it's important to consider the context of the other values.</li>\n<li><strong>HCO3-</strong>is 44 mEq/L (normal range: 22-26 mEq/L). This value is significantly elevated, indicating a primary metabolic cause.</li>\n</ul>\n</li>\n<li><strong>Assess Compensation</strong>: The elevated PaCO2 in this context is likely a compensatory mechanism to balance the increased pH from the high bicarbonate. This supports the diagnosis of a metabolic disorder, as the respiratory system is compensating by retaining more CO2 (a respiratory acid).</li>\n</ol>\n<h3>Correct Answer: Choice D) Metabolic Alkalosis</h3>\n<ul>\n<li><strong>Explanation</strong>: The high bicarbonate level is the primary cause of the alkalosis. The patient's symptoms of nausea, vomiting, and diarrhea often lead to loss of stomach acid or volume contraction, which can trigger an increase in bicarbonate reabsorption and production, thereby causing metabolic alkalosis. The respiratory system compensates by retaining CO2.</li>\n</ul>\n<h3>Explanation of Incorrect Choices:</h3>\n<ul>\n<li><strong>Choice </strong><strong>A) Respiratory Acidosis</strong>\n<ul>\n<li><strong>Incorrect Because</strong>: This condition is characterized by a primary increase in CO2. Although the CO2 is elevated here, it's a compensatory response to the metabolic alkalosis, not the primary disorder.</li>\n</ul>\n</li>\n<li><strong>Choice </strong><strong>B) Respiratory Alkalosis</strong>\n<ul>\n<li><strong>Incorrect Because</strong>: Would typically present with a decreased PaCO2 due to hyperventilation. In this case, PaCO2 is increased as a compensatory mechanism.</li>\n</ul>\n</li>\n<li><strong>Choice </strong><strong>C) Metabolic Acidosis</strong>\n<ul>\n<li><strong>Incorrect Because</strong>: This would be indicated by a decreased bicarbonate level and generally accompanied by a decrease in pH (academia), not an increase.</li>\n</ul>\n</li>\n</ul>\n<h3><strong>Key Takeaway:</strong></h3>\n<p><strong>Metabolic alkalosis</strong> is confirmed by <strong>elevated HCO<sub>3</sub><sup>-</sup></strong> and <strong>high pH</strong>, with compensatory <strong>CO<sub>2</sub> retention</strong> (PaCO<sub>2</sub>&gt; 45 mmHg).</p>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-anion Gap metabolic acidosis </span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">High anion Gap metabolic acidosis</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Compensated metabolic alkalosis </span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented to the emergency department with abdominal pain, vomiting, tachypnea and tachycardia. Lab reports are shown below: Na is 135 mEq/L;  K is 5 meq/l; bicarbonate is 12meq/L; chloride is 92 meq/l; RBS = 450 mg/dl. What is the diagnosis?</span></p>",
      "unique_key": "DT1324039",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324039,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250506b379746d-ea8f-4c3d-af28-d131383060dc.jpg\">\n<p>Given:</p>\n<ul>\n<li><strong>Na</strong>: 135 mEq/L</li>\n<li><strong>Cl</strong>: 92 mEq/L</li>\n<li><strong>HCO3 (bicarbonate)</strong>: 12 mEq/L</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250506868ce28c-79a0-4796-b167-36813d7ab06e.jpg\">\n<p>The normal range for the anion gap is typically 8-12 mEq/L. A gap of 31 mEq/L indicates a high anion gap.</p>\n<p><strong>Correct Answer : Choice B) High Anion Gap Metabolic Acidosis</strong></p>\n<ul>\n<li><strong>Explanation</strong>: The high anion gap metabolic acidosis is consistent with the presented lab values, especially with the elevated random blood sugar (RBS = 450 mg/dl), suggesting diabetic ketoacidosis (DKA) as a possible underlying cause. DKA is often associated with abdominal pain, vomiting, tachypnoea, and tachycardia, symptoms that fit the patient's presentation. High anion gap acidosis in DKA results from the accumulation of ketoacids.</li>\n</ul>\n<p><strong>Explanation of Incorrect Options:</strong></p>\n<ul>\n<li><strong>Choice </strong><strong>A) Non-anion Gap Metabolic Acidosis</strong>\n<ul>\n<li><strong>Incorrect Because</strong>: This would be suggested if the anion gap were normal (8-12 mEq/L). Non-anion gap metabolic acidosis is typically due to direct losses of bicarbonate (e.g., diarrhea), or accumulation of chloride, neither of which is indicated here.</li>\n</ul>\n</li>\n<li><strong>Choice </strong><strong>C) Compensated Metabolic Alkalosis</strong>\n<ul>\n<li><strong>Incorrect Because</strong>: Metabolic alkalosis would feature an elevated bicarbonate level, opposite to what is observed. Compensated metabolic alkalosis would show normal pH due to respiratory compensation (increased CO2), not applicable here.</li>\n</ul>\n</li>\n<li><strong>Choice </strong><strong>D) Respiratory Acidosis</strong>\n<ul>\n<li><strong>Incorrect Because</strong>: Respiratory acidosis would involve elevated CO2 levels due to hypoventilation. The patient's tachypnoea suggests the opposite effect-likely an attempt to compensate for metabolic acidosis.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>A high anion gap metabolic acidosis (AG = 31) with hyperglycemia suggests DKA as the most likely cause.</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Spleen </span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Kidney </span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Lungs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Erythropoietin is produced by? \r\n\r\n</span></p>",
      "unique_key": "DT1324040",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324040,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The physiologic regulator of red cell production, the glycoprotein hormone EPO, is produced and released by peritubular capillary lining cells within the kidney. These cells are highly specialized epithelial-like cells. A small amount of EPO is produced by hepatocytes. The funda- mental stimulus for EPO production is the availability of O2 for tissue metabolic needs. Key to EPO gene regulation is hypoxia-inducible factor (HIF)-1&alpha;. In the presence of O2, HIF-1&alpha; is hydroxylated at a key proline, allowing HIF-1&alpha; to be ubiquitinated and degraded via the proteasome pathway. If O2 becomes limiting, this critical hydroxylation step does not occur, allowing HIF-1&alpha; to partner with other proteins, translocate to the nucleus, and upregulate the expression of the EPO gene, among others.</p>\n<p><strong>Explanation of Incorrect Options:</strong></p>\n<ul>\n<li><strong>Choice A: Liver - </strong>The <strong>liver produces EPO during fetal development</strong>, but in adults, it contributes only a <strong>small percentage (~10%)</strong>of total EPO production.</li>\n<li><strong>Choice B: Spleen - </strong>The <strong>spleen is not involved in EPO production</strong>. It primarily functions in <strong>red blood cell (RBC) recycling </strong>and <strong>immune response</strong>.</li>\n<li><strong>Choice D: Lungs - </strong>The <strong>lungs are not involved in EPO production</strong>. They regulate oxygen exchange but do not produce erythropoietin.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>The kidney is the primary site of EPO production in adults, with a small contribution from the liver. Hypoxia-inducible factor (HIF-1&alpha;) regulates its synthesis.</p>",
      "correct_choice_id": 123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Unstable angina </span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">NSTEMI</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior Wall MI</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute myocarditis </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\"> A 55-year-old male presented with acute onset of chest pain  to the emergency department. ECG was taken. What is the likely diagnosis? <img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/2025050606acdd72-58bb-4249-bd70-ef42e917b285.jpg\"></span></p>",
      "unique_key": "DT1324041",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324041,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<h1>ECG Analysis and Myocardial Infarction Localization</h1>\r\n<h2>ECG Analysis:</h2>\r\n<p>The ECG shows ST-segment depressions in leads V1-V3, indicative of a posterior wall myocardial infarction (MI). This pattern suggests reciprocal changes typical of posterior MI, associated often with inferior or lateral involvement.</p>\r\n<h2>Likely Diagnosis:</h2>\r\n<p><strong>Choice C) Posterior Wall MI</strong></p>\r\n<p>Explanation: The reciprocal ST depressions in V1-V3 suggest a posterior wall MI. Direct leads for the posterior wall are not part of a standard ECG setup, and these changes are diagnostic clues.</p>\r\n<h2> Incorrect Choices explanation :</h2>\r\n<p><strong>Choice A) Unstable Angina:</strong> Typically does not show definitive ECG changes like those observed, often non-specific.<br /><strong>Choice B) NSTEMI:</strong> Presents with ST depressions and/or T-wave inversions; however, specific patterns observed are more indicative of a posterior wall MI.<br /><strong>Choice D) Acute Myocarditis: </strong>Can mimic acute MI symptoms with non-specific ECG changes, but the specific pattern seen is more suggestive of ischemia due to posterior wall MI.</p>\r\n<h2>ECG Localization of MI:</h2>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250506a4d1cb16-a2f4-4ac7-8cb7-14285d1d748a.jpg\">\r\n<h3><strong>Key Takeaway:</strong></h3>\r\n<p>ST depressions in V1-V3 suggest a posterior MI due to reciprocal changes. Diagnosis can be confirmed with posterior leads (V7-V9), which would show ST elevations.</p>\r\n<p><strong>Reference : </strong>https://litfl.com/posterior-myocardial-infarction-ecg-library/</p>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Synchronized DC cardioversion </span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">IV adenosine 6 mg bolus</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Carotid massage</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">IV amiodarone bolus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presented to the emergency department in a drowsy state. He was in hypotension and ECG revealed narrow complex tachycardia. What is the next best step in management? \r\n \r\n\r\n</span></p>",
      "unique_key": "DT1324042",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324042,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Acute Management of Paroxysmal Supraventricular Tachycardia (PSVT)</strong></p>\r\n<ol>\r\n<li><strong>ECG Monitoring:</strong>Continuous ECG monitoring is crucial for all patients. A 12-lead ECG is essential when possible to help determine the mechanism of PSVT.</li>\r\n<li><strong>Initial Assessment:</strong>Check for signs of hemodynamic instability such as hypotension, unconsciousness, or respiratory distress.</li>\r\n<li><strong>Immediate Actions for Unstable Patients:</strong>\r\n<ul>\r\n<li>If the patient is hypotensive and shows signs of distress, <strong>synchronized direct current (DC) cardioversion</strong>is indicated and is effective.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Stable Patients:</strong>\r\n<ul>\r\n<li><strong>Vagal Maneuvers:</strong>Carotid sinus massage and Valsalva maneuver are first-line responses to attempt termination of PSVT in cooperative and appropriate patients (low risk of carotid disease).</li>\r\n<li><strong>Pharmacological Interventions:</strong>If vagal maneuvers fail, intravenous adenosine is typically the next step. It effectively terminates most PSVTs by temporarily blocking AV nodal conduction.</li>\r\n<li><strong>Side Effects of Adenosine:</strong>May include chest pain, dyspnea, and brief arrhythmias like atrial fibrillation (AF).</li>\r\n<li><strong>Contraindications of Adenosine:</strong>Avoid in patients with cardiac transplantation or those with WPW syndrome where AF may lead to severe complications.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Alternative Medications:</strong>\r\n<ul>\r\n<li><strong>Beta Blockers and Calcium Channel Blockers:</strong>These are alternatives if adenosine is contraindicated or ineffective but can cause hypotension and have longer effects.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Differential Diagnosis:</strong>\r\n<ul>\r\n<li>Consider wide-complex tachycardias like ventricular tachycardia, which must be managed cautiously, often as ventricular tachycardia until proven otherwise.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Wide-complex Tachycardia Management:</strong>\r\n<ul>\r\n<li>Regular wide-complex tachycardia in a stable patient may be tested with IV adenosine. However, very irregular wide-complex tachycardia might indicate preexcited AF and should be managed aggressively with cardioversion or antiarrhythmic drugs like procainamide.</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<p><strong>Explanation for the Given Scenario:</strong></p>\r\n<p>Given the presentation of hypotension and a narrow complex tachycardia in a drowsy patient, the immediate concern is the patient's hemodynamic stability.</p>\r\n<p><strong>Correct Answer for the Scenario: A) Synchronized DC cardioversion</strong></p>\r\n<ul>\r\n<li><strong>Rationale:</strong>For patients presenting with PSVT and signs of hemodynamic instability like hypotension, immediate synchronized DC cardioversion is recommended to quickly restore normal heart rhythm and stabilize the patient.</li>\r\n</ul>\r\n<p><strong>Incorrect </strong><strong>Choices Explanation </strong><strong>:</strong></p>\r\n<p><strong>Choice </strong><strong>B) IV Adenosine 6 mg bolus</strong></p>\r\n<ul>\r\n<li><strong>Incorrect Because:</strong>While adenosine is effective for terminating PSVT, it is not appropriate in the presence of hypotension as it might further lower blood pressure or lead to brief periods of asystole.</li>\r\n</ul>\r\n<p><strong>Choice </strong><strong>C) Carotid Massage</strong></p>\r\n<ul>\r\n<li><strong>Incorrect Because:</strong>This could be dangerous in a hypotensive patient and generally should not be the first line in an emergency setting without prior assessment of carotid artery health.</li>\r\n</ul>\r\n<p><strong>Choice </strong><strong>D) IV Amiodarone bolus</strong></p>\r\n<ul>\r\n<li><strong>Incorrect Because:</strong>Amiodarone is used for ventricular arrhythmias or when other medications are contraindicated. It's not typically the first choice for acute PSVT and could complicate the arrhythmia management.</li>\r\n</ul>\r\n<h3><strong>Key Takeaway:</strong></h3>\r\n<p>In unstable narrow complex tachycardia (hypotension, altered mental status, shock), immediate synchronized DC cardioversion is the best choice.</p>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulsus paradoxus may be seen </span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Loud S1 is expected </span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Emergency pericardiocentesis may be required </span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">ECHO may show diastolic collapse of RA and RV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female presents to the emergency department with breathlessness. She was having tachycardia with BP of 100/70 mm Hg. She had a viral infection followed by chest pain 7 days ago. A chest x ray revealed a \"water bottle\" sign. All of the following statements are true except?  </span></p>",
      "unique_key": "DT1324043",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324043,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Choice B) Loud S1 is expected</strong></p>\r\n<ul>\r\n<li><strong>Incorrect</strong>: A loud S1 is not typically expected in the setting of pericarditis or pericardial effusion. Instead, heart sounds may actually be muffled or diminished due to the fluid damping the transmission of sound.<strong> </strong></li>\r\n</ul>\r\n<p><strong>Incorrect choices explanation </strong><strong>:</strong></p>\r\n<p><strong>Choice </strong><strong>A) Pulsus paradoxus may be seen</strong></p>\r\n<ul>\r\n<li><strong>Correct</strong>: This is true for cases of pericardial effusion, particularly when there's significant fluid accumulation leading to cardiac tamponade. Pulsus paradoxus is a drop in blood pressure greater than 10 mm Hg during inspiration and is a classic sign of tamponade.</li>\r\n</ul>\r\n<p><strong>Choice </strong><strong>C) Emergency pericardiocentesis may be required</strong></p>\r\n<ul>\r\n<li><strong>Correct</strong>: In cases where there is significant pericardial effusion leading to cardiac tamponade, as suggested by the \"water bottle\" sign on chest X-ray and accompanying hemodynamic instability, emergency pericardiocentesis is necessary to relieve pressure from the heart.</li>\r\n</ul>\r\n<p><strong>Choice </strong><strong>D) ECG may show diastolic collapse of RA and RV</strong></p>\r\n<ul>\r\n<li><strong>Incorrect</strong>: Diastolic collapse of the right atrium (RA) and right ventricle (RV) would be noted on echocardiography, not ECG. ECG findings in pericardial effusion might include low voltage and electrical alternans, but not diastolic collapse of heart chambers.</li>\r\n</ul>\r\n<p><strong>PERICARDITIS: </strong></p>\r\n<ol>\r\n<li><strong>Non-specific Therapy for Acute Idiopathic Pericarditis:</strong>\r\n<ul>\r\n<li>Bed rest is recommended.</li>\r\n<li>Anti-inflammatory treatment with high-dose aspirin or NSAIDs such as ibuprofen or indomethacin, alongside gastric protection like omeprazole.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Colchicine Use:</strong>\r\n<ul>\r\n<li>Administered for three months to enhance NSAID response and reduce recurrence risk.</li>\r\n<li>Dosage depends on patient weight (0.5 mg qd for &lt;70 kg, 0.5 mg bid for &gt;70 kg).</li>\r\n<li>May cause gastrointestinal side effects; contraindicated in hepatic or renal dysfunction.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Glucocorticoids:</strong>\r\n<ul>\r\n<li>Used if NSAIDs and colchicine are ineffective or not tolerated.</li>\r\n<li>Short-term use only due to increased risk of recurrence.</li>\r\n<li>Tapering after 2-4 days of full-dose use is necessary.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Anticoagulants:</strong>\r\n<ul>\r\n<li>Generally avoided due to the risk of bleeding into the pericardial cavity, which can lead to tamponade.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Management of Recurrent Cases:</strong>\r\n<ul>\r\n<li>For multiple, frequent recurrences lasting over two years, treatment with immune modulators like azathioprine or anakinra may be beneficial.</li>\r\n<li>Pericardial stripping may be considered but doesn't guarantee prevention of recurrence.</li>\r\n</ul>\r\n</li>\r\n<li><strong>Outpatient Management:</strong>\r\n<ul>\r\n<li>Most acute pericarditis cases are managed outpatient unless specific risky conditions are suspected.</li>\r\n<li>Hospitalization recommended for suspected serious etiologies or presence of poor prognosis indicators.</li>\r\n</ul>\r\n</li>\r\n</ol>\r\n<h3><strong>Key Takeaway:</strong></h3>\r\n<ul>\r\n<li><strong>Muffled heart sounds</strong>(not a loud S1) are characteristic of pericardial effusion/tamponade.</li>\r\n<li><strong>Pulsus paradoxus, emergency pericardiocentesis, and diastolic chamber collapse</strong>are classic findings.</li>\r\n</ul>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Rare occurrence in individuals with a normal heart </span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Direct cardioversion must be done for all cases  </span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous digoxin for rate control </span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Discrepancy in HR and PR can be used for supporting diagnosis </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\"> Which of the following statements is false regarding a 35-year-old male presenting to the emergency department with unconsciousness and the ECG showing atrial fibrillation? <img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250506ab9c0cb0-a230-46ad-9214-2a026153b8c9.jpg\"> </span></p>",
      "unique_key": "DT1324044",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324044,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Choice B) Direct cardioversion must be done for all cases</strong></p>\r\n<ul>\r\n<li><strong>False</strong>: Direct cardioversion is not indicated for all cases of atrial fibrillation. The decision to perform cardioversion depends on the duration of AF, the presence of hemodynamic instability, and whether the patient has been anticoagulated adequately if the AF has been <strong>present for more than 48 hours</strong><strong>.</strong></li>\r\n<li><strong>Explanation</strong>: This statement is false because cardioversion, whether pharmacologic or electrical, is reserved for specific clinical situations and is not a universal requirement for all AF cases. </li>\r\n</ul>\r\n<p>Incorrect choices explanation : </p>\r\n<p><strong>Choice </strong><strong>A) Rare occurrence in individuals with a normal heart</strong></p>\r\n<ul>\r\n<li><strong>False</strong>: Atrial fibrillation (AF) can indeed occur in individuals with structurally normal hearts, especially in the presence of triggering factors such as alcohol use, caffeine, stress, or sleep apnea. However, it is more commonly associated with underlying heart disease.</li>\r\n</ul>\r\n<p><strong> Choice </strong><strong>C) Intravenous digoxin for rate control</strong></p>\r\n<ul>\r\n<li><strong>True</strong>: Intravenous digoxin can be used for rate control in AF, particularly in patients with heart failure. It is effective in controlling ventricular rate, especially in non-urgent situations.</li>\r\n</ul>\r\n<p><strong>Choice </strong><strong>D) Discrepancy in HR and PR can be used for supporting diagnosis</strong></p>\r\n<ul>\r\n<li><strong>True</strong>: In AF, there is typically an irregular rhythm with varying PR intervals which supports the diagnosis. The heart rate is irregularly irregular, and pulse rate may not match the heart rate detected on an ECG due to pulse deficit.</li>\r\n</ul>\r\n<h1>Management of Atrial Fibrillation</h1>\r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202505065a52d4e9-5ff7-48f9-babd-463a33ad9054.jpg\">\r\n<h3><strong>Key Takeaway:</strong></h3>\r\n<ul>\r\n<li><strong>Cardioversion is NOT universally required in AF.</strong></li>\r\n<li><strong>Indications for immediate cardioversion:</strong>Hemodynamic instability.</li>\r\n<li><strong>In stable patients:</strong><strong>Rate control (digoxin, beta-blockers, CCBs) and anticoagulation</strong> are preferred.</li>\r\n</ul>\r\n<p><strong>Reference : </strong>https://litfl.com/atrial-fibrillation-ecg-library/</p>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest compressions 100 to 120/ minute </span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest compressions 3 to 4 cm depth </span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Allow complete Chest  recoil </span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Compression: ventilation ratio is 30:2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\"> Which Is not correct about high quality CPR? </span></p>",
      "unique_key": "DT1324045",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324045,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The immediate response to sudden cardiac arrest (SCA), as described in the provided text:</p>\n<ol>\n<li><strong>Checking for Response</strong>:\n<ul>\n<li>The rescuer should first check if the victim is responsive, looking for any signs of consciousness or movement.</li>\n</ul>\n</li>\n<li><strong>Assessment of Airway and Breathing</strong>:\n<ul>\n<li>If airway obstruction or aspiration is suspected, perform the Heimlich maneuver to clear the airway.</li>\n<li>Check for a pulse for no longer than 10 seconds to avoid delaying chest compressions.</li>\n<li>Assess the patient's breathing. Note that gasping respirations and brief seizure-like activity may occur during SCA and should not be mistaken for normal breathing.</li>\n</ul>\n</li>\n<li><strong>Initiation of Chest Compressions</strong>:\n<ul>\n<li>Begin chest compressions immediately if no pulse is found.</li>\n<li>Compressions should be at a rate of 100-120 per minute, depressing the sternum by 5 cm (2 inches), and allowing the chest to fully recoil between compressions.</li>\n</ul>\n</li>\n<li><strong>Mechanics of Chest Compressions</strong>:\n<ul>\n<li>Chest compressions help generate forward cardiac output through the sequential filling and emptying of the cardiac chambers, with heart valves ensuring the forward flow of blood.</li>\n</ul>\n</li>\n<li><strong>Minimizing Interruptions</strong>:\n<ul>\n<li>Interruptions in chest compressions should be minimized to reduce the risk of end-organ ischemia.</li>\n</ul>\n</li>\n<li><strong>Ventilation Technique</strong>:\n<ul>\n<li>If a trained rescuer is present, administer two breaths for every 30 compressions.</li>\n<li>Untrained bystanders should perform \"hands-only CPR (chest compressions without rescue breaths), which has been shown to be similarly beneficial and easier to perform correctly.</li>\n</ul>\n</li>\n<li><strong>Use of Automated External Defibrillator (AED)</strong>:\n<ul>\n<li>If a second rescuer is available, they should immediately seek an AED, which is often available in public spaces.</li>\n</ul>\n</li>\n<li><strong>Continued Assistance</strong>:\n<ul>\n<li>Follow the instructions from emergency medical services (EMS) upon their arrival and continue support as directed.</li>\n</ul>\n</li>\n</ol>\n<p><strong>Incorrect Choices Explanation:</strong></p>\n<p><strong>Choice A: Chest compressions 100 to 120/minute</strong></p>\n<ul>\n<li><strong>Correct</strong>. The recommended compression rate for high-quality CPR is between <strong>100 and 120 compressions per minute </strong>to optimize circulation.</li>\n<li>A rate below 100 may not provide sufficient perfusion, while exceeding 120 can reduce effectiveness due to incomplete recoil.</li>\n</ul>\n<p><strong>Choice C: Allow complete chest recoil</strong></p>\n<ul>\n<li><strong>Correct</strong>. Complete recoil ensures the heart fully refills between compressions, maintaining cardiac output.</li>\n<li>Incomplete recoil reduces venous return and stroke volume, decreasing perfusion to vital organs.</li>\n</ul>\n<p><strong>Choice D: Compression: ventilation ratio is 30:2</strong></p>\n<ul>\n<li><strong>Correct</strong>. The <strong>standard ratio for adult CPR with a single rescuer is 30 compressions to 2 ventilations</strong>.</li>\n<li>This ensures adequate oxygenation while prioritizing continuous chest compressions.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<ul>\n<li>Correct compression depth is 5-6 cm, not 3-4 cm.</li>\n<li>Maintain a rate of 100-120 compressions per minute.</li>\n<li>Allow full chest recoil to optimize circulation.</li>\n<li>Follow a 30:2 compression-to-ventilation ratio in single-rescuer CPR.</li>\n</ul>",
      "correct_choice_id": 172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone </span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Aztreonam  </span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Piperacillin </span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Vancomycin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs can be safely used in a patient with enterococcal endocarditis with penicillin allergy? </span></p>",
      "unique_key": "DT1324046",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324046,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202505064ed73699-674a-4f98-9d36-b61193ac2f17.jpg\">\n<p><strong>Incorrect Choices Explanation:</strong></p>\n<p><strong>Choice A: Ceftriaxone</strong></p>\n<ul>\n<li><strong>Incorrect </strong>because ceftriaxone alone <strong>has poor activity against enterococci</strong>.</li>\n<li>While it can be used <strong>in combination with ampicillin</strong>for synergistic killing, it is not a suitable monotherapy for enterococcal endocarditis.</li>\n</ul>\n<p><strong>Choice B: Aztreonam</strong></p>\n<ul>\n<li><strong>Incorrect </strong>because aztreonam has <strong>no significant activity against Gram-positive bacteria</strong>, including enterococci.</li>\n<li>It is primarily used against Gram-negative aerobes, making it ineffective for enterococcal infections.</li>\n</ul>\n<p><strong>Choice C: Piperacillin</strong></p>\n<ul>\n<li><strong>Incorrect </strong>because piperacillin is a <strong>penicillin-class antibiotic</strong>, which <strong>should be avoided in patients with penicillin allergy</strong>.</li>\n<li>Though active against enterococci, cross-reactivity in penicillin-allergic patients makes it unsafe.</li>\n</ul>\n<h3><strong>Key Takeaway:</strong></h3>\n<ul>\n<li>Vancomycin is the safest choice for enterococcal endocarditis in penicillin-allergic patients.</li>\n<li>Ceftriaxone requires ampicillin for synergy but is ineffective alone.</li>\n<li>Aztreonam lacks activity against enterococci.</li>\n<li>Piperacillin is contraindicated due to penicillin allergy.</li>\n</ul>",
      "correct_choice_id": 184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Quadriplegia </span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventricular tachycardia   </span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerebral edema</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Diabetes insipidus\r\n</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-Year-Old male is admitted to the medicine department with complaints of recurrent episodes of vomiting and diarrhea. On lab evaluation, serum potassium level was 3 meq/l. All of the following are possible complications except? \r\n</span></p>",
      "unique_key": "DT1324047",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324047,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Clinical Features of Hypokalemia</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250509eb96eefe-6cb9-4a15-ba3e-8465bffa74a4.JPG\">\n<p><strong>Incorrect Choices Explanation:</strong></p>\n<p><strong>Choice A: Quadriplegia</strong></p>\n<ul>\n<li><strong>Correct </strong>because severe hypokalemia can cause <strong>profound muscle weakness, progressing to quadriplegia</strong>.</li>\n<li>Hypokalemia <strong>reduces resting membrane potential</strong>, leading to <strong>impaired neuromuscular transmission</strong>and muscle paralysis.</li>\n</ul>\n<p><strong>Choice B: Ventricular Tachycardia</strong></p>\n<ul>\n<li><strong>Correct </strong>because <strong>hypokalemia increases the risk of arrhythmias</strong>, including <strong>ventricular tachycardia and torsades de pointes</strong>.</li>\n<li>Low potassium levels <strong>prolong repolarization (QT interval)</strong>and <strong>increase automaticity</strong>, predisposing the heart to <strong>lethal arrhythmias</strong>.</li>\n</ul>\n<p><strong>Choice D: Diabetes Insipidus</strong></p>\n<ul>\n<li><strong>Correct </strong>because <strong>hypokalemia impairs renal concentrating ability</strong>, leading to <strong>nephrogenic diabetes insipidus (DI)</strong>.</li>\n<li>Potassium depletion <strong>reduces aquaporin-2 expression in renal tubules</strong>, causing <strong>polyuria and polydipsia</strong>.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<ul>\n<li>Hypokalemia can cause neuromuscular (quadriplegia), cardiac (ventricular tachycardia), and renal (diabetes insipidus) complications.</li>\n<li>Cerebral edema is NOT a known direct complication of hypokalemia.</li>\n</ul>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">Dapsone</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">Rifampicin  </span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">Clofazimine </span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">Ofloxacin \r\n</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which drug used in the treatment of leprosy can result in hyperpigmentation?</span></p>",
      "unique_key": "DT1324048",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324048,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<h1><strong>Summary of Leprosy Drugs</strong></h1>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/2025050914b260e1-1663-4761-a5d9-c46f66ae2198.JPG\">\n<h3><strong>Key Takeaway:</strong></h3>\n<ul>\n<li>Clofazimine is the only anti-leprosy drug that causes skin hyperpigmentation.</li>\n<li>Other leprosy drugs (dapsone, rifampicin, ofloxacin) do not cause this side effect.</li>\n</ul>",
      "correct_choice_id": 203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Fall of oxygen saturation triggering waking up at night </span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased tone of the pharyngeal muscles worsens obstruction </span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Low oxygen stimulates respiratory effort </span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Apneic episodes increase the stress on the heart  \r\n</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\"> A 45-year-old man presents with complaints of excessive daytime sleepiness. His wife also reports that he snores a lot at night. Choose the incorrect statement regarding this condition? </span></p>",
      "unique_key": "DT1324049",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324049,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<h3>Definition of OSA:</h3>\n<ol>\n<li><strong>Diagnostic Criteria:</strong>\n<ul>\n<li>The presence of either nighttime symptoms (snoring, snorting, gasping, breathing pauses) or daytime sleepiness/fatigue unexplained by other medical conditions.</li>\n<li>Documented evidence of five or more episodes of obstructive apnea or hypopnea per hour of sleep (Apnea-Hypopnea Index [AHI]) during a sleep study.</li>\n<li>OSA can also be diagnosed with an AHI of &ge;15 episodes/hour in the absence of symptoms.</li>\n</ul>\n</li>\n</ol>\n<h3>Pathophysiology of OSA:</h3>\n<ol>\n<li><strong>Intraluminal Pharyngeal Pressure:</strong>\n<ul>\n<li>During inspiration, negative pressure in the pharynx increases, creating a suction force.</li>\n<li>The pharyngeal airway lacks rigid structural support, relying instead on pharyngeal dilator muscles.</li>\n</ul>\n</li>\n<li><strong>Muscle Activity and Airway Patency:</strong>\n<ul>\n<li>Pharyngeal dilator muscles are active during wakefulness but their output decreases during sleep.</li>\n<li>Reduction in neuromuscular output can lead to pharyngeal collapse or near collapse, manifesting as apnea or hypopneas.</li>\n</ul>\n</li>\n<li><strong>Response to Collapse:</strong>\n<ul>\n<li>Collapses usually end when ventilatory reflexes trigger arousal, increasing muscular activity and reopening the airway.</li>\n</ul>\n</li>\n<li><strong>Common Sites of Airway Collapse:</strong>\n<ul>\n<li>Soft palate, tongue base, lateral pharyngeal walls, and epiglottis.</li>\n<li>Severity of OSA can increase during REM sleep and in the supine position due to reduced neuromuscular tone and gravitational effects.</li>\n</ul>\n</li>\n</ol>\n<h3>Contributing Factors to OSA:</h3>\n<ol>\n<li><strong>Anatomical Predispositions:</strong>\n<ul>\n<li>Individuals with smaller pharyngeal lumens need higher neuromuscular activation to maintain airway patency.</li>\n<li>Enlarged soft tissues or craniofacial abnormalities can narrow the airway.</li>\n</ul>\n</li>\n<li><strong>Influence of Lung Volumes:</strong>\n<ul>\n<li>Low lung volumes reduce caudal traction on the pharynx, reducing pharyngeal wall stiffness and contributing to collapse.</li>\n</ul>\n</li>\n<li><strong>Nasal Resistance:</strong>\n<ul>\n<li>High nasal resistance can intensify pharyngeal collapse by lowering intraluminal pressure and potentially leading to mouth opening during sleep.</li>\n</ul>\n</li>\n<li><strong>Ventilatory Drive and Control:</strong>\n<ul>\n<li>Sensitivity to CO2, arousal thresholds, and neuromuscular responses play significant roles.</li>\n<li>Fluctuations in CO2 levels during sleep can alter ventilation and upper airway stiffness, influencing the likelihood of pharyngeal collapse.</li>\n</ul>\n</li>\n<li><strong>Role of Arousal Thresholds:</strong>\n<ul>\n<li>Low arousal thresholds can interrupt the compensatory pharyngeal muscle activity too early.</li>\n<li>High arousal thresholds may delay the termination of apnea, worsening desaturation.</li>\n</ul>\n</li>\n<li><strong>Muscular Compensation Impairments:</strong>\n<ul>\n<li>Any deficiency in muscular response during sleep can lead to or exacerbate pharyngeal collapse.</li>\n</ul>\n</li>\n</ol>\n<p><strong>Incorrect Choices Explanation:</strong></p>\n<p><strong>Choice A: Fall of oxygen saturation triggering waking up at night</strong></p>\n<ul>\n<li><strong>Correct statement </strong>because <strong>hypoxia and hypercapnia</strong> trigger arousals during sleep, leading to fragmented sleep and excessive daytime sleepiness.</li>\n<li>The brain responds to oxygen desaturation by <strong>briefly waking the patient up </strong>to restore normal breathing.</li>\n</ul>\n<p><strong>Choice C: Low oxygen stimulates respiratory effort</strong></p>\n<ul>\n<li><strong>Correct statement </strong>because when oxygen levels drop, <strong>chemoreceptors in the brainstem</strong> detect the hypoxia and increase respiratory drive to compensate.</li>\n<li>This effort to breathe can lead to <strong>labored breathing, snorting, and gasping episodes </strong>during sleep.</li>\n</ul>\n<p><strong>Choice D: Apneic episodes increase the stress on the heart</strong></p>\n<ul>\n<li><strong>Correct statement </strong>because <strong>repeated apnea episodes</strong> cause <strong>hypoxia, hypercapnia, and sympathetic activation</strong>, which can lead to:\n<ul>\n<li>Hypertension</li>\n<li>Arrhythmias</li>\n<li>Increased risk of cardiovascular diseases like heart failure and stroke</li>\n</ul>\n</li>\n</ul>\n<h3><strong>Key Takeaway:</strong></h3>\n<ul>\n<li><strong>Obstructive Sleep Apnea (OSA) is caused by decreased pharyngeal muscle tone, not increased tone.</strong></li>\n<li>Hypoxia-induced arousals and increased respiratory effort contribute to the sleep disturbances and cardiovascular risks associated with OSA.</li>\n</ul>",
      "correct_choice_id": 212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic liver disease  </span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Nephrotic syndrome </span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Chronic venous insufficiency </span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Lupus nephritis\r\n</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is not a common cause of chronic bipedal edema?</span></p>",
      "unique_key": "DT1324050",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324050,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Major Causes of Edema</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202505066fcb93ec-c689-44fc-b4b1-32d524c2d036.jpg\">\n<p><strong>Incorrect Choices Explanation:</strong></p>\n<p><strong>Choice A: Chronic liver disease</strong></p>\n<ul>\n<li><strong>Correct statement </strong>because <strong>hepatic cirrhosis</strong> causes <strong>hypoalbuminemia, portal hypertension, and secondary hyperaldosteronism</strong>, all leading to <strong>fluid retention and edema</strong>.</li>\n<li>Edema in liver disease is often <strong>dependent and associated with ascites</strong>.</li>\n</ul>\n<p><strong>Choice B: Nephrotic syndrome</strong></p>\n<ul>\n<li><strong>Correct statement </strong>because <strong>massive protein loss in urine</strong> results in <strong>hypoalbuminemia</strong>, reducing oncotic pressure and leading to <strong>fluid shift into the interstitial space</strong>.</li>\n<li>Nephrotic syndrome causes <strong>generalized edema</strong>, including <strong>bipedal and periorbital edema</strong>.</li>\n</ul>\n<p><strong>Choice D: Chronic venous insufficiency</strong></p>\n<ul>\n<li><strong>Correct statement </strong>because it is a <strong>leading cause of chronic bipedal edema</strong>, especially in <strong>elderly or sedentary patients</strong>.</li>\n<li>Venous valve incompetence leads to <strong>venous hypertension, capillary leakage, and fluid accumulation</strong>, causing <strong>edema, skin changes (hyperpigmentation, ulceration), and varicose veins</strong>.</li>\n</ul>\n<h3><strong>Key Takeaway:</strong></h3>\n<ul>\n<li>Chronic bipedal edema is commonly caused by heart failure, nephrotic syndrome, chronic venous insufficiency, and liver disease.</li>\n<li>Lupus nephritis can cause bipedal edema but is typically categorized under nephrotic or nephritic syndromes rather than a primary cause of chronic edema.</li>\n</ul>",
      "correct_choice_id": 223,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">First onset at 50 years of age </span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Temporal artery tenderness </span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Subacute progression over 4 weeks </span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">Cocaine use</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following scenarios warrant extensive evaluation of headache etiology except? </span></p>",
      "unique_key": "DT1324051",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324051,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202505067e0505f8-edc5-45c2-8370-0dcd96121168.jpg\">\n<p><strong>Choice D: Cocaine use</strong></p>\n<ul>\n<li><strong>Incorrect statement </strong>because while cocaine can cause headaches (due to vasoconstriction, hypertension, or rebound dilation), it does not <strong>necessarily</strong> warrant an extensive evaluation unless other red flags are present.</li>\n<li>Cocaine-related headaches are often <strong>acute, transient, and associated with drug use</strong>, and management primarily involves <strong>discontinuation of use and symptom control</strong>.</li>\n</ul>\n<h3><strong>Incorrect Choices Explanation:</strong></h3>\n<p><strong>Choice A: First onset at 50 years of age</strong></p>\n<ul>\n<li><strong>Correct statement </strong>because new-onset headache in an individual <strong>over 50</strong> is a <strong>red flag</strong> for serious conditions like <strong>giant cell arteritis, malignancy, or intracranial pathology</strong>.</li>\n<li>Evaluation should include <strong>neuroimaging and inflammatory markers (ESR, CRP)</strong>.</li>\n</ul>\n<p><strong>Choice B: Temporal artery tenderness</strong></p>\n<ul>\n<li><strong>Correct statement </strong>because temporal artery tenderness is <strong>highly suggestive of giant cell arteritis (GCA)</strong>, which can lead to <strong>vision loss if untreated</strong>.</li>\n<li>Urgent evaluation with <strong>ESR, CRP, and temporal artery biopsy</strong>is required.</li>\n</ul>\n<p><strong>Choice C: Subacute progression over 4 weeks</strong></p>\n<ul>\n<li><strong>Correct statement </strong>because headaches that <strong>gradually worsen over weeks</strong> suggest an underlying cause like <strong>brain tumors, subdural hematomas, or chronic meningitis</strong>.</li>\n<li>Neuroimaging (MRI/CT) is indicated.</li>\n</ul>\n<h3><strong>Key Takeaway:</strong></h3>\n<ul>\n<li>Headaches warranting urgent evaluation include new onset in older adults, focal neurological signs, progressive worsening, and systemic symptoms.</li>\n<li>Cocaine use can cause headaches but does not always necessitate an extensive workup unless red flags are present.</li>\n</ul>",
      "correct_choice_id": 234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">Lennox Gastaut syndrome </span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">Tuberous sclerosis </span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">Dravet syndrome </span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Rett syndrome\r\n\r\n</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cannabidiol Is not approved for treatment of? \r\n\r\n</span></p>",
      "unique_key": "DT1324052",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324052,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/2025050644841b8d-74ab-421b-823d-35f23590041d.jpg\">\n<br>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250506c330059e-5af8-4b26-a4d3-0f0b4e6a2907.jpg\">\n<p><strong>Choice D: Rett syndrome</strong></p>\n<ul>\n<li><strong>Incorrect statement </strong>because cannabidiol (CBD) is <strong>not</strong> FDA-approved for the treatment of <strong>Rett syndrome</strong>.</li>\n<li>Rett syndrome is a <strong>genetic neurological disorder </strong>primarily affecting females, caused by mutations in the <strong>MECP2 gene</strong>.</li>\n<li>Treatment focuses on <strong>symptomatic management</strong>(physical therapy, speech therapy, medications for seizures and spasticity), but <strong>CBD is not an approved therapy</strong> for this condition.</li>\n</ul>\n<p><strong>Incorrect Choices Explanation:</strong></p>\n<p><strong>Choice A: Lennox-Gastaut syndrome</strong></p>\n<ul>\n<li><strong>Correct statement </strong>because CBD (Epidiolex) is <strong>FDA-approved</strong> for Lennox-Gastaut syndrome (LGS), a severe <strong>childhood-onset epileptic encephalopathy</strong> characterized by <strong>multiple seizure types and cognitive impairment</strong>.</li>\n<li>Approved based on studies showing CBD <strong>reduces seizure frequency </strong>in LGS patients.</li>\n</ul>\n<p><strong>Choice B: Tuberous sclerosis</strong></p>\n<ul>\n<li><strong>Correct statement </strong>because CBD is <strong>FDA-approved</strong> for <strong>seizures associated with tuberous sclerosis complex (TSC)</strong>.</li>\n<li>TSC is a <strong>genetic disorder causing benign tumors in multiple organs</strong>, often leading to <strong>epilepsy, intellectual disability, and skin abnormalities</strong>.</li>\n<li>Studies have shown that CBD <strong>helps in reducing seizure burden </strong>in TSC patients.</li>\n</ul>\n<p><strong>Choice C: Dravet syndrome</strong></p>\n<ul>\n<li><strong>Correct statement </strong>because CBD is <strong>FDA-approved</strong> for <strong>Dravet syndrome</strong>, a <strong>severe genetic epilepsy syndrome </strong>seen in infancy.</li>\n<li>It is characterized by <strong>prolonged febrile seizures, developmental delay, and drug-resistant epilepsy</strong>.</li>\n<li>Epidiolex has demonstrated efficacy in <strong>reducing seizure frequency </strong>in these patients.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<p>Cannabidiol (CBD) is FDA-approved for Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis but NOT for Rett syndrome.</p>",
      "correct_choice_id": 244,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">N1  stage of NREM sleep </span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">N2 stage of NREM sleep </span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">N3  stage of NREM sleep </span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">REM sleep\r\n\r\n</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The representation shown below is suggestive of? \r\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/2025050656f1ff5a-c0bf-4ed1-bf89-31b00e0120ac.jpg\">\r\n\r\n</span></p>",
      "unique_key": "DT1324053",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324053,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Hint is that there is no activity in the skeletal muscles which can be only seen in REM phase. Please see the text below.</strong> </p>\n<p>Polysomnography is a comprehensive recording technique used to measure various physiological parameters during sleep, such as brain electrical activity (EEG), eye movements (EOG), and muscle activity (EMG). It helps to distinguish between different stages of sleep based on these recordings.</p>\n<ol>\n<li><strong>Non-Rapid Eye Movement (NREM) Sleep:</strong>\n<ul>\n<li><strong>NREM sleep </strong>is subdivided into three stages: N1, N2, and N3.</li>\n<li><strong>Stage N1:</strong> This initial stage of sleep features a transition from wakefulness to sleep and is characterized by a light sleep state. The EEG shows a reduction in background frequency, which is generally low amplitude and mixed frequency, similar to that observed in relaxed wakefulness.</li>\n<li><strong>Stage N2:</strong>This is a deeper sleep stage than N1 and is characterized by the appearance of specific EEG waveforms such as sleep spindles and K-complexes. These features help protect sleep from external disturbances.</li>\n<li><strong>Stage N3:</strong> Known as deep or slow-wave sleep, this stage exhibits high-amplitude, low-frequency delta waves on the EEG. It represents the deepest sleep and the highest threshold for arousal.</li>\n</ul>\n</li>\n<li><strong>Rapid Eye Movement (REM) Sleep:</strong>\n<ul>\n<li><strong>REM sleep</strong> features a low-amplitude, mixed-frequency EEG that is similar to the N1 stage but distinct due to the presence of rapid eye movements.</li>\n<li>The EOG records bursts or flurries of rapid eye movements, which are characteristic of this stage.</li>\n<li><strong>EMG activity is notably absent in almost all skeletal muscles, except those involved in respiration. This muscle atonia (paralysis) is mediated by the brainstem and prevents the sleeper from acting out dreams.</strong></li>\n</ul>\n</li>\n</ol>\n<h3><strong>Incorrect Choices Explanation:</strong></h3>\n<p><strong>Choice A: N1 stage of NREM sleep</strong></p>\n<ul>\n<li><strong>N1 sleep</strong> is a <strong>light sleep stage</strong> that acts as a transition between wakefulness and sleep.</li>\n<li><strong>Key Features:</strong>\n<ul>\n<li>EEG: <strong>Low-voltage, mixed-frequency activity</strong>(theta waves).</li>\n<li>EOG: <strong>Slow rolling eye movements</strong>may be seen.</li>\n<li>EMG: <strong>Slight muscle tone persists</strong>, unlike REM sleep.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Choice B: N2 stage of NREM sleep</strong></p>\n<ul>\n<li><strong>N2 sleep </strong>is the most predominant sleep stage and represents a deeper level of sleep compared to N1.</li>\n<li><strong>Key Features:</strong>\n<ul>\n<li>EEG: Presence of <strong>sleep spindles and K-complexes</strong>.</li>\n<li>EOG: No rapid eye movements.</li>\n<li>EMG: <strong>Muscle tone is present</strong>, though reduced.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Choice C: N3 stage of NREM sleep</strong></p>\n<ul>\n<li><strong>N3 sleep (slow-wave sleep)</strong>is the <strong>deepest stage of NREM sleep</strong> and is crucial for physical restoration.</li>\n<li><strong>Key Features:</strong>\n<ul>\n<li>EEG: <strong>High-amplitude, low-frequency delta waves</strong>.</li>\n<li>EOG: No rapid eye movements.</li>\n<li>EMG: <strong>Muscle tone is still present</strong>, unlike REM sleep.</li>\n</ul>\n</li>\n</ul>\n<h3><strong>Key Takeaway:</strong></h3>\n<p>REM sleep is the only sleep stage with near-total muscle atonia, preventing voluntary movement, which distinguishes it from NREM sleep stages.</p>",
      "correct_choice_id": 254,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Continuous pattern of involvement rather than skip lesions </span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Commonly manifests with hematochezia</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">No increased risk of colon cancer</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Peri-anal fistulas are frequent </span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\"> In comparison with ulcerative colitis, choose the true statement about Crohn's disease? </span></p>",
      "unique_key": "DT1324054",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324054,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<h1>Crohn's Disease and Ulcerative Colitis</h1>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/202505097b63c1e6-217e-449f-a5ed-aaf67bd4902d.JPG\">\n<h3><strong>Incorrect Choices Explanation:</strong></h3>\n<p><strong>Choice A: Continuous pattern of involvement rather than skip lesions</strong></p>\n<ul>\n<li><strong>False</strong>: Crohn's disease exhibits <strong>skip lesions</strong>(patchy areas of disease with normal segments in between), whereas <strong>ulcerative colitis (UC) has continuous involvement</strong> from the rectum proximally.</li>\n</ul>\n<p><strong>Choice B: Commonly manifests with hematochezia</strong></p>\n<ul>\n<li><strong>False</strong>: <strong>Hematochezia (bloody diarrhea)</strong>is more characteristic of <strong>ulcerative colitis</strong> due to its superficial mucosal inflammation and ulceration.</li>\n<li><strong>Crohn's disease</strong>more commonly presents with <strong>non-bloody diarrhea, abdominal pain, and weight loss</strong>.</li>\n</ul>\n<p><strong>Choice C: No increased risk of colon cancer</strong></p>\n<ul>\n<li><strong>False</strong>: Both <strong>Crohn's disease</strong>(especially with colonic involvement) and <strong>ulcerative colitis</strong> increase the risk of <strong>colorectal cancer</strong> due to chronic inflammation.</li>\n</ul>\n<h3><strong>Key Takeaway:</strong></h3>\n<p>Perianal fistulas are a hallmark of Crohn's disease, distinguishing it from ulcerative colitis.</p>",
      "correct_choice_id": 264,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer lactulose </span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Perform endoscopy to assess for varices</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Initiate treatment with thiamine and chlordiazepoxide </span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Do CT brain\r\n</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male who is a chronic alcoholic presents to the emergency department with multiple bouts of vomiting and altered sensorium. HIs previous binge intake of alcohol was 7 days ago. He was in hypotension when he presented to the emergency department. Ultrasound showed a small liver with coarse echotexture and portal vein dilation. What is the most appropriate next step in managing the patient? \r\n</span></p>",
      "unique_key": "DT1324055",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324055,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Patient is likely having hepatic encephalopathy. As there are certain points against alcohol withdrawal. Harrison says : If the patient agrees to stop drinking, sudden decreases in alcohol intake can produce withdrawal symptoms, most of which are the opposite of those produced by intoxication. Features include tremor of the hands (shakes); agitation and anxiety; autonomic nervous system overactivity including an increase in pulse, respiratory rate, sweating, and body temperature; and insomnia. These symptoms usually begin within 5-10 h of decreasing ethanol intake, peak on day 2 or 3, and improve by day 4 or 5, although mild levels of these problems may persist for 4-6 months as a protracted abstinence syndrome.</p>\n<p><em>The most urgent will be IVF administration along with antiemetics which is not in option so best answer will be lactulose.</em></p>\n<p>For the 60-year-old male with chronic alcohol use who presents with vomiting, altered sensorium, hypotension, and signs of chronic liver disease (small liver with coarse echotexture and portal vein dilation), the most appropriate next steps in management involve addressing multiple facets of his presentation.</p>\n<p>Choice A) <strong>Administer Lactulose</strong></p>\n<p>Lactulose is used primarily for the treatment of hepatic encephalopathy by reducing the absorption of ammonia in the colon.</p>\n<p>Incorrect choices explanation:</p>\n<p>Choice B) <strong>Perform Endoscopy to Assess for Varices</strong></p>\n<p>Given the ultrasound findings of portal vein dilation, there is a risk of portal hypertension which may lead to esophageal varices. While an important step, it might not be the most immediate action needed given the patient's altered sensorium and hypotension.</p>\n<p>Choice C) <strong>Initiate Treatment with Thiamine and Chlordiazepoxide</strong></p>\n<p>Thiamine should be administered to prevent Wernicke's encephalopathy, which is a serious risk in alcoholic patients presenting with symptoms like altered mental status. Chlordiazepoxide can be considered for alcohol withdrawal symptoms, though it should be used cautiously given the patient's liver status and current presentation of hypotension.</p>\n<p>Choice D) <strong>Do CT Brain</strong></p>\n<p>This would be essential if there's a suspicion of an acute neurological event such as hemorrhage or stroke, especially in the context of vomiting and altered sensorium. However, it may not be the most immediate need unless there are focal neurological signs or symptoms.</p>\n<p><strong>Most Appropriate Next Step:</strong></p>\n<p><strong>Option C (Initiate treatment with Thiamine and Chlordiazepoxide)</strong> is the most appropriate initial step. Administering thiamine is crucial to prevent further neurological damage, and addressing potential alcohol withdrawal safely is vital given the patient's presentation and history.</p>\n<p><strong> Therapy for Hepatic Encephalopathy:</strong></p>\n<ul>\n<li><strong>Clinical Features: </strong>Confusion, personality change, asterixis (\"liver flap\"), potential for violence or lethargy, and precipitating factors like high protein intake, infection, or electrolyte imbalances.</li>\n<li><strong>Treatment: </strong>Management includes lactulose for reducing ammonia absorption, possibly rifaximin or other antibiotics if lactulose is insufficient, addressing precipitating factors like infections or electrolyte issues, and careful use of medications considering the patient's liver function.</li>\n</ul>\n<h3><strong>Key Takeaway:</strong></h3>\n<ul>\n<li><strong>Lactulose is the first-line treatment for hepatic encephalopathy </strong>in cirrhotic patients.</li>\n<li><strong>Thiamine should be given to prevent Wernicke's encephalopathy, but benzodiazepines should be avoided</strong> due to hepatic encephalopathy.</li>\n</ul>",
      "correct_choice_id": 271,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">Skin rashes</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">Gastrointestinal hemorrhage </span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">Abdominal pain</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">Arthritis \r\n</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following symptoms suggests the use of steroids in IgA vasculitis?</span></p>",
      "unique_key": "DT1324056",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324056,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Severe gastrointestinal vasculitis manifestations including severe abdominal pain or gastrointestinal bleeding are indications for steroids. The word severe is missing from abdominal pain. Therefore it is not the correct option. Haemorrhage indicates severe vasculitic manifestation.</p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250506383bf6d0-6352-44af-8787-f9cab16bf45b.jpg\">\n<br>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0;\"src=\"https://d3fkkq5frqjyl8.cloudfront.net/V4/NEETPGMCQ/20250506ed5a107c-7f4f-4329-830a-f6933c56d167.jpg\">\n<h3><strong>Incorrect Choices Explanation:</strong></h3>\n<p><strong>Choice A: Skin rashes</strong></p>\n<ul>\n<li><strong>IgA vasculitis presents with a purpuric rash</strong>, but <strong>cutaneous involvement alone does not warrant steroid therapy </strong>unless associated with severe ulceration or necrosis.</li>\n<li><strong>Management is usually supportive</strong>, with hydration and NSAIDs for mild symptoms.</li>\n</ul>\n<p><strong>Choice C: Abdominal pain</strong></p>\n<ul>\n<li><strong>Mild to moderate abdominal pain is common in IgA vasculitis</strong> due to <strong>intestinal vasculitis</strong>, but <strong>steroids are not indicated unless the pain is severe, persistent, or complicated by hemorrhage, bowel ischemia, or intussusception</strong>.</li>\n<li>Since the <strong>word \"severe\" is missing</strong>, this option is incorrect.</li>\n</ul>\n<p><strong>Choice D: Arthritis</strong></p>\n<ul>\n<li><strong>IgA vasculitis commonly causes transient, non-erosive arthritis/arthralgia</strong>, which is usually <strong>self-limiting and does not require steroids</strong>.</li>\n<li><strong>NSAIDs or acetaminophen</strong> are preferred for symptomatic relief.</li>\n</ul>\n<p><strong>Key Takeaway:</strong></p>\n<ul>\n<li>Steroids are used in IgA vasculitis for severe GI manifestations, particularly GI hemorrhage.</li>\n<li>Mild to moderate symptoms, such as skin rash, arthritis, or mild abdominal pain, do not require steroids.</li>\n</ul>",
      "correct_choice_id": 282,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">Primary hyperparathyroidism </span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">Pheochromocytoma </span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperthyroidism </span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">Mineral bone disorder\r\n</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\"> A patient presents to the OPD with symptoms of headache, lethargy, abdominal pain and developed recurrent renal stones. Serum calcium is high and PTH is high. What is the likely diagnosis? \r\n</span></p>",
      "unique_key": "DT1324057",
      "question_audio": null,
      "question_video": null,
      "map_id": 1324057,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Choice </strong><strong>A) Primary Hyperparathyroidism</strong><br />This diagnosis is suggested by the combination of high serum calcium and elevated parathyroid hormone (PTH) levels, alongside symptoms of headache, lethargy, abdominal pain, and recurrent renal stones. These are classic signs of primary hyperparathyroidism, where there is an overproduction of PTH leading to increased calcium levels, often resulting from a parathyroid adenoma.<strong> </strong></p>\r\n<p><strong>Choice </strong><strong>A) Primary Hyperparathyroidism</strong><br />Correct diagnosis due to elevated calcium and PTH, and symptomatic presentation consistent with the disease.<strong> </strong></p>\r\n<p><strong>Incorrect choices explanation : </strong></p>\r\n<p><strong>Choice </strong><strong>B) Pheochromocytoma</strong><br />Incorrect because it typically presents with symptoms of hypertension, headaches, palpitations, and sweating due to excess catecholamine production, not directly linked to high calcium or PTH levels.</p>\r\n<p><strong>Choice </strong><strong>C) Hyperthyroidism</strong><br />Incorrect as it generally causes symptoms like weight loss, increased heart rate, and hyperactivity, and while it can cause elevated calcium levels, it does not typically result in elevated PTH levels.</p>\r\n<p><strong>Choice </strong><strong>D) Mineral Bone Disorder</strong><br />Incorrect as this is more commonly associated with chronic kidney disease and involves disturbances in calcium, phosphate, PTH, and vitamin D metabolism, not typically presenting with elevated PTH as a primary problem.</p>\r\n<p><strong>Syndromes Associated with Hyperparathyroidism:</strong></p>\r\n<ul>\r\n<li><strong>MEN 1 (Wermer's syndrome)</strong>: Includes hyperparathyroidism, pituitary tumors, pancreatic tumors, often with gastric hypersecretion and peptic ulcers.</li>\r\n<li><strong>MEN 2A</strong>: Includes pheochromocytoma, medullary carcinoma of the thyroid, and hyperparathyroidism.</li>\r\n<li><strong>Hyperparathyroidism-Jaw Tumor (HPT-JT) syndrome</strong>: Involves parathyroid tumors and benign jaw tumors, linked to mutations in the CDC73 gene.</li>\r\n<li><strong>Nonsyndromic Familial Isolated Hyperparathyroidism (FIHP)</strong>: Linked to mutations in GCM2 and possibly variable expression of other syndromes like MEN 1 or MEN 2.</li>\r\n</ul>\r\n<p><strong>Signs and Symptoms of Primary Hyperparathyroidism:</strong></p>\r\n<ul>\r\n<li><strong>Renal Involvement</strong>: Recurrent nephrolithiasis, nephrocalcinosis, decreased renal function.</li>\r\n<li><strong>Skeletal System</strong>: Osteitis fibrosa cystica (historically), bone resorption, reduced bone density.</li>\r\n<li><strong>Neuromuscular and CNS Involvement</strong>: Muscle weakness, fatigue, possible neuropsychiatric manifestations.</li>\r\n<li><strong>Gastrointestinal Issues</strong>: Vague abdominal complaints, potential for peptic ulcer disease in MEN 1 associated cases.</li>\r\n</ul>\r\n<h3><strong>Key Takeaway:</strong></h3>\r\n<p>Primary Hyperparathyroidism is the most likely diagnosis in a patient with recurrent renal stones, hypercalcemia, and elevated PTH.</p>",
      "correct_choice_id": 291,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}